These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 11866683)

  • 1. Seretide for obstructive lung disease.
    Chapman KR
    Expert Opin Pharmacother; 2002 Mar; 3(3):341-50. PubMed ID: 11866683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhaled salmeterol/fluticasone propionate: a review of its use in asthma.
    Reynolds NA; Lyseng-Williamson KA; Wiseman LR
    Drugs; 2005; 65(12):1715-34. PubMed ID: 16060707
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhaled salmeterol/fluticasone propionate combination: a pharmacoeconomic review of its use in the management of asthma.
    Lyseng-Williamson KA; Plosker GL
    Pharmacoeconomics; 2003; 21(13):951-89. PubMed ID: 12959627
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhaled salmeterol/fluticasone propionate: a review of its use in chronic obstructive pulmonary disease.
    Fenton C; Keating GM
    Drugs; 2004; 64(17):1975-96. PubMed ID: 15329047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Salmeterol/fluticasone propionate: a review of its use in the treatment of chronic obstructive pulmonary disease.
    Keating GM; McCormack PL
    Drugs; 2007; 67(16):2383-405. PubMed ID: 17983257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Salmeterol/fluticasone propionate (50/500 microg) in combination in a Diskus inhaler (Seretide) is effective and safe in the treatment of steroid-dependent asthma.
    Aubier M; Pieters WR; Schlösser NJ; Steinmetz KO
    Respir Med; 1999 Dec; 93(12):876-84. PubMed ID: 10653049
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhaled salmeterol/fluticasone propionate combination: a review of its use in persistent asthma.
    Markham A; Jarvis B
    Drugs; 2000 Nov; 60(5):1207-33. PubMed ID: 11129128
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Seretide: a pharmacoeconomic analysis.
    Fritscher L; Chapman KR
    J Med Econ; 2008; 11(3):555-70. PubMed ID: 19450105
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Salmeterol/fluticasone propionate: a review of its use in asthma.
    McKeage K; Keam SJ
    Drugs; 2009; 69(13):1799-828. PubMed ID: 19719334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluticasone propionate/salmeterol for the treatment of chronic-obstructive pulmonary disease.
    Dransfield MT; Bailey WC
    Expert Opin Pharmacother; 2004 Aug; 5(8):1815-26. PubMed ID: 15264996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluticasone versus salmeterol/low-dose fluticasone for long-term asthma control.
    Heyneman CA; Crafts R; Holland J; Arnold AD
    Ann Pharmacother; 2002 Dec; 36(12):1944-9. PubMed ID: 12452759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Salmeterol and fluticasone propionate (50/250 microg) administered via combination Diskus inhaler: as effective as when given via separate Diskus inhalers.
    Chapman KR; Ringdal N; Backer V; Palmqvist M; Saarelainen S; Briggs M
    Can Respir J; 1999; 6(1):45-51. PubMed ID: 10202220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-effectiveness of salmeterol xinafoate/fluticasone propionate combination inhaler in chronic asthma.
    Doull I; Price D; Thomas M; Hawkins N; Stamuli E; Tabberer M; Gosden T; Rudge H
    Curr Med Res Opin; 2007 May; 23(5):1147-59. PubMed ID: 17519082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics and pharmacodynamics of fluticasone propionate and salmeterol delivered as a combination dry powder from a capsule-based inhaler and a multidose inhaler in asthma and COPD patients.
    Daley-Yates PT; Mehta R; Chan RH; Despa SX; Louey MD
    J Aerosol Med Pulm Drug Deliv; 2014 Aug; 27(4):279-89. PubMed ID: 24074143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of fluticasone propionate/salmeterol combination therapy in preventing exacerbations of COPD.
    Yawn BP; Raphiou I; Hurley JS; Dalal AA
    Int J Chron Obstruct Pulmon Dis; 2010 Jun; 5():165-78. PubMed ID: 20631816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advair: combination treatment with fluticasone propionate/salmeterol in the treatment of asthma.
    Nelson HS
    J Allergy Clin Immunol; 2001 Feb; 107(2):398-416. PubMed ID: 11174215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhaled salmeterol/fluticasone propionate combination in chronic obstructive pulmonary disease.
    Lyseng-Williamson KA; Keating GM
    Am J Respir Med; 2002; 1(4):273-82; discussion 283-4. PubMed ID: 14720047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Step-down therapy with low-dose fluticasone-salmeterol combination or medium-dose hydrofluoroalkane 134a-beclomethasone alone.
    Fowler SJ; Currie GP; Lipworth BJ
    J Allergy Clin Immunol; 2002 Jun; 109(6):929-35. PubMed ID: 12063520
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The efficacy and safety of fluticasone propionate (250 microg)/salmeterol (50 microg) combined in the Diskus inhaler for the treatment of COPD.
    Hanania NA; Darken P; Horstman D; Reisner C; Lee B; Davis S; Shah T
    Chest; 2003 Sep; 124(3):834-43. PubMed ID: 12970006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhaled corticosteroids or long-acting beta-agonists alone or in fixed-dose combinations in asthma treatment: a systematic review of fluticasone/budesonide and formoterol/salmeterol.
    Frois C; Wu EQ; Ray S; Colice GL
    Clin Ther; 2009 Dec; 31(12):2779-803. PubMed ID: 20110019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.